Log in to save to my catalogue

Current and Emerging Cell Culture Manufacturing Technologies for Influenza Vaccines

Current and Emerging Cell Culture Manufacturing Technologies for Influenza Vaccines

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4359798

Current and Emerging Cell Culture Manufacturing Technologies for Influenza Vaccines

About this item

Full title

Current and Emerging Cell Culture Manufacturing Technologies for Influenza Vaccines

Publisher

Cairo, Egypt: Hindawi Publishing Corporation

Journal title

BioMed research international, 2015-01, Vol.2015 (2015), p.1-11

Language

English

Formats

Publication information

Publisher

Cairo, Egypt: Hindawi Publishing Corporation

More information

Scope and Contents

Contents

Annually, influenza virus infects millions of people worldwide. Vaccination programs against seasonal influenza infections require the production of hundreds of million doses within a very short period of time. The influenza vaccine is currently produced using a technology developed in the 1940s that relies on replicating the virus in embryonated h...

Alternative Titles

Full title

Current and Emerging Cell Culture Manufacturing Technologies for Influenza Vaccines

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4359798

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4359798

Other Identifiers

ISSN

2314-6133

E-ISSN

2314-6141

DOI

10.1155/2015/504831

How to access this item